Corvidia

Read more
Marc De Garidel's photo - CEO of Corvidia

CEO

Marc De Garidel

CEO Approval Rating

76/100

Founded:

2014

Status:

CORVIDIA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Marc De Garidel

CEO

- -
25
$86M
$7.2M
View Profile
1

Anirvan Ghosh

CEO

89/100
106
$323.6M
$1.4M
View Profile
2

Rick Pauls

President & CEO

83/100
10
$17.5M
$4.7M
View Profile
3

James Plant

Chairman & CEO

81/100
30
$10M
$5M
View Profile
4

Paul A. Friedman

Chairman & CEO

85/100
17
$38.4M
$ < 1M
View Profile
5

Tassos Gianakakos

CEO

94/100
165
$114.4M
$33.6M
View Profile
6

Fouzia Laghrissi-Thode

CEO

77/100
53
$150M
$5M
View Profile
7

Dennis Dalangin

CEO

82/100
29
$11.1M
$7.8M
View Profile
8

Roy Cosan

Interim-CEO

88/100
35
$7.5M
$4.8M
View Profile
9

Filippo Petti

CEO

87/100
81
$232.6M
$ < 1M
View Profile
10

Rachelle MacSweeney

President & CEO

70/100
155
- -
$24.2M
View Profile

Missing a competitor? Contribute!

UNITY is a top competitor of Corvidia. UNITY was founded in South San Francisco, California} in 2011. UNITY competes in the Biotechnology industry. Compared to Corvidia, UNITY generates $5.8M less revenue.

DiaMedica is Corvidia's #2 competitor. DiaMedica is headquartered in Minneapolis, Minnesota, and was founded in 2000. DiaMedica competes in the Pharmaceuticals field. DiaMedica generates 65% the revenue of Corvidia.

KLOTHO Therapeutics, Inc. has been one of Corvidia's top competitors. KLOTHO Therapeutics, Inc. is a Private company that was founded in 2016 in San Diego, California. KLOTHO Therapeutics, Inc. operates in the Pharmaceuticals industry. Compared to Corvidia, KLOTHO Therapeutics, Inc. has 5 more employees.

Corvidia Acquisitions

No recent acquisitions found related to Corvidia

Corvidia Funding History

Since Corvidia was founded in 2014, it has participated in 2 rounds of funding. In total Corvidia has raised $86.0M. Corvidia's last funding round was on Apr 2018 for a total of $60.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Apr 2018
$60M

Venrock

Series A
Feb 2016
$26M

Since Corvidia was founded in 2014, it has participated in 2 rounds of funding. In total Corvidia has raised $86.0M. Corvidia's last funding round was on Apr 2018 for a total of $60.0M

Corvidia Investments

No recent investments found related to Corvidia

Corvidia News

Corvidia Press Releases

Social Media

Corvidia Headquarters

35 Gatehouse Drive

Waltham, Massachusetts02451

1-781-205-4755

Driving Directions »

Trending Companies

Corvidia Summary

ABOUT

Overview

Corvidia is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders. Corvidia was founded in 2014. Corvidia's headquarters is located in Waltham, Massachusetts, USA 02451....

CEO

Corvidia's CEO, Marc De Garidel, currently has an approval rating of 76%. Corvidia's primary competitors are UNITY, DiaMedica & KLOTHO Therapeutics, Inc..

Frequently Asked Questions about Corvidia

  1. When was Corvidia founded?

    Corvidia was founded in 2014
  2. Who is Corvidia's CEO?

    Corvidia's CEO is Marc De Garidel
  3. How much revenue does Corvidia generate?

    Corvidia generates $7.2M in revenue
  4. How much funding does Corvidia have?

    Corvidia has historically raised $86M in funding
  1. Where is Corvidia's headquarters?

    Corvidia's headquarters is in Waltham Massachusetts, USA
  2. How many employees does Corvidia have?

    Corvidia has 25 employees
  3. What sector does Corvidia operate in?

    Corvidia is in Biotechnology
  4. Who are Corvidia's competitors?

    Corvidia's top competitors are UNITY, DiaMedica, KLOTHO Therapeutics, Inc.